These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23946775)

  • 1. Expression and clinical significance of complement C3, complement C4b1 and apolipoprotein E in pancreatic cancer.
    Chen J; Wu W; Zhen C; Zhou H; Yang R; Chen L; Hu L
    Oncol Lett; 2013 Jul; 6(1):43-48. PubMed ID: 23946775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.
    Chen J; Wu W; Chen L; Zhou H; Yang R; Hu L; Zhao Y
    Pancreatology; 2013; 13(3):290-7. PubMed ID: 23719603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations of TNM staging and lymph node metastasis of gastric cancer with MRI features and VEGF expression.
    Pang L; Wang J; Fan Y; Xu R; Bai Y; Bai L
    Cancer Biomark; 2018; 23(1):53-59. PubMed ID: 30010108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer.
    Lian S; Zhai X; Wang X; Zhu H; Zhang S; Wang W; Wang Z; Huang J
    Medicine (Baltimore); 2016 Jul; 95(30):e4328. PubMed ID: 27472713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between S100A4 protein expression and pre-operative serum CA19.9 levels in pancreatic carcinoma and its prognostic significance.
    Jia F; Liu M; Li X; Zhang F; Yue S; Liu J
    World J Surg Oncol; 2019 Sep; 17(1):163. PubMed ID: 31526392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LOX-1 is a poor prognostic indicator and induces epithelial-mesenchymal transition and metastasis in pancreatic cancer patients.
    Zhang J; Zhang L; Li C; Yang C; Li L; Song S; Wu H; Liu F; Wang L; Gu J
    Cell Oncol (Dordr); 2018 Feb; 41(1):73-84. PubMed ID: 29168159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and clinical significance of AHSG and complement C3 in pancreatic ductal adenocarcinoma].
    Chen J; Wu W; Chen L; Ma X; Zhao Y; Zhou H; Yang R; Hu L
    Zhonghua Yi Xue Za Zhi; 2014 Jul; 94(28):2175-9. PubMed ID: 25331466
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Zhao Z; Zou S; Guan X; Wang M; Jiang Z; Liu Z; Li C; Lin H; Liu X; Yang R; Gao Y; Wang X
    Front Genet; 2018; 9():650. PubMed ID: 30631342
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical significance of vascular endothelial growth factor and connexin43 for predicting pancreatic cancer clinicopathologic parameters.
    Liang QL; Wang BR; Chen GQ; Li GH; Xu YY
    Med Oncol; 2010 Dec; 27(4):1164-70. PubMed ID: 19908168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement component 3 is a prognostic factor of non‑small cell lung cancer.
    Lin K; He S; He L; Chen J; Cheng X; Zhang G; Zhu B
    Mol Med Rep; 2014 Aug; 10(2):811-7. PubMed ID: 24819254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer.
    Sun L; Guo C; Cao J; Burnett J; Yang Z; Ran Y; Sun D
    Int J Med Sci; 2017; 14(7):655-661. PubMed ID: 28824297
    [No Abstract]   [Full Text] [Related]  

  • 12. High Expression of Cell Division Cycle 42 Promotes Pancreatic Cancer Growth and Predicts Poor Outcome of Pancreatic Cancer Patients.
    Yang D; Zhang Y; Cheng Y; Hong L; Wang C; Wei Z; Cai Q; Yan R
    Dig Dis Sci; 2017 Apr; 62(4):958-967. PubMed ID: 28181096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum apolipoprotein E is associated with metastasis and poor prognosis of non-small cell lung cancer.
    Luo J; Song J; Feng P; Wang Y; Long W; Liu M; Li L
    Tumour Biol; 2016 Aug; 37(8):10715-21. PubMed ID: 26873483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding to erythrocyte complement receptor type 1 of BSA/anti-BSA complexes opsonized by C4A3 or C4B1 in the presence of serum.
    Klint C; Truedsson L; Sturfelt G
    Scand J Immunol; 1995 Oct; 42(4):425-32. PubMed ID: 7569775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression.
    Yuan K; Ye J; Liu Z; Ren Y; He W; Xu J; He Y; Yuan Y
    J Exp Clin Cancer Res; 2020 Jan; 39(1):9. PubMed ID: 31928530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma.
    Chen J; Chen LJ; Yang RB; Xia YL; Zhou HC; Wu W; Lu Y; Hu LW; Zhao Y
    Med Oncol; 2013; 30(2):583. PubMed ID: 23609192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of Preoperative and Postoperative Complement C3 Depletion in Gastric Cancer: A Three-Year Survival Investigation.
    Ye J; Ren Y; Chen J; Song W; Chen C; Cai S; Tan M; Yuan Y; He Y
    Biomed Res Int; 2017; 2017():2161840. PubMed ID: 29062836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of CA 19.9 and LINC01197 in pancreatic cancer.
    Jia YH; Zheng WW; Ye ZH
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2358-2367. PubMed ID: 32196587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.
    Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z
    Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.